 REACH is
likely to make extensive use of surrogate data, by predicting
properties from chemical structure, other measured properties
or testing analogues. This process can be linked with making
use of data waivers justified on the grounds of low exposure.
Making maximum use of existing published data, surrogate data
and waivers will allow for 'intelligent toxicity testing' to
minimise the cost and animal usage, yet provide information
to assess the hazardous properties and conduct a risk assessment.
As a consequence, testing is by no means a routine 'box-ticking'
exercise and will require expert involvement. Risk assessment
is central to REACH and based on our experience with notification
of new chemicals and registration of biocides, preliminary
risk assessments are likely to be pivotal in deciding whether
to proceed with registration under REACH.
Our Registration staff have extensive experience with:
- Risk Assessments
- Negotiating with Regulatory Agencies
- Use of Surrogate Data (Literature, Rea-Across, SAR etc)
- Dossier Preparation
- Chemical Safety Reports
By conducting preliminary Risk Assessments on your products,
we can help you determine your obligations under REACH and
formulate a testing strategy to save time and money in the
process.
|
